METHODS	Postmenopausal women at increased risk for breast cancer ( breast density 25 % ) were randomized to : ( 1 ) no intervention ; ( 2 ) Ral 60 mg ; ( 3 ) Ral 30 mg ; ( 4 ) n-3FA ( Lovaza ) 4 g and ( 5 ) Lovaza 4 g + Ral 30 mg for 2 years .\